Comparison of gastro-oesophageal junction carcinomas in Chinese versus American patients

Histopathology

Volumn 59, Issue 2, 2011, Pages 188-197

  Huang, Qin ^a,b,c   Fan, Xiangshan ^a   Agoston, Agoston T ^d   Feng, Anning ^e   Yu, Huiping ^a   Lauwers, Gregory ^c,f   Zhang, Lihua ^a   Odze, Robert D ^c,d  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NANJING MEDICAL UNIVERSITY   (China)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

American; Carcinoma; Chinese; Gastric cardia; Gastro oesophageal; Oesophagus; Stomach

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CHINA; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTRITIS; GASTROINTESTINAL CARCINOMA; GASTROOESOPHAGEAL JUNCTION CARCINOMA; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; UNITED STATES;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BARRETT ESOPHAGUS; CHINA; CROSS-CULTURAL COMPARISON; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE; UNITED STATES;

HELICOBACTER PYLORI;

EID: 80052221283     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03924.x     Document Type: Article

References (46)

1. Spechler SJ, Dixon MF, Genta R. Adenocarcinoma of the esophgogastric junction. In Hamilton SR, Aaltonen LA eds. Pathology and genetics of tumours of the digestive system, World Health Organization classification of tumour. Lyon: IARC, 2000; 32-36.
2. Siewert JR, Stein HJ. Classification of adenocarcinoma of the esophagogastric junction. Br. J. Surg. 1998; 85; 1457-1459.
3. McColl KEL, Going J. Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia. Gut 2010; 59; 282-284.
4. Wijnhoven BP, Siersema PD, Hop WC et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Esophageal Tumour Study Group. Br. J. Surg. 1999; 86; 529-535.
5. Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J. Surg. Oncol. 2005; 90; 139-146.
6. Chandrasoma P, Wickramasinghe K, Ma Y et al. Adenocarcinomas of the distal oesophagus and 'gastric cardia' are predominantly esophageal carcinomas. Am. J. Surg. Pathol. 2007; 31; 569-575.
7. Whitson BA, Groth SS, Li Z, Kratzke RA, Maddaus MA. Survival of patients with distal esophageal and gastric cardia tumors: a population-based analysis of gastroesophageal junction carcinomas. Thorac. Cardiovasc. Surg. 2010; 139; 43-48.
8. Blot WJ, Devesa SS, Kneller RW et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J. Am. Med. Assoc. 1991; 265; 1287-1289.
9. Crane SJ, Richard LG 3rd, Harmsen WS et al. The changing incidence of esophageal and gastric adenocarcinoma by anatomic sub-site. Aliment. Pharmacol. Ther. 2007; 25; 447-453.
10. Pera M, Cameron AJ, Trastek VF et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104; 1-3.
11. Lagergren J, Bergström R, Lindgren A et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999; 340; 825-831.
12. Chow WH, Blot WJ, Vaughan TL et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J. Natl Cancer Inst. 1998; 90; 150-155.
13. Camerson AJ, Lomboy CT, Pera M et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109; 1541-1546.
14. Portale G, Peters JH, Hagen JA et al. Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without Barrett mucosa. Arch. Surg. 2005; 140; 570-574.
15. Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction. Scand. J. Surg. 2006; 95; 260-269.
16. Wang LD, Zheng S, Zheng ZY et al. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J. Gastroenterol. 2003; 9; 1156-1164.
17. Huang Q, Zhang LH. The histopathologic spectrum of carcinomas involving the gastroesophageal junction in the Chinese. Int. J. Surg. Pathol. 2007; 15; 38-52.
18. Fang WL, Wu CW, Chen JH et al. Esophagogastric junction adenocarcinoma. According to Siewert Classification in Taiwan. Ann. Surg. Oncol. 2009; 16; 3237-3244.
19. Wu JC. Gastroesophageal reflux disease: an Asian perspective. J. Gastroenterol. Hepatol. 2008; 23; 1785-1793.
20. Yee YK, Cheung TK, Chan AO et al. Decreasing trend of esophageal adenocarcinoma in Hong Kong. Cancer Epidemiol. Biomarkers Prev. 2007; 16; 2637-2640.
21. Lam KD, Phan JT, Garcia RT et al. Low proportion of Barrett's esophagus in Asian Americans. Am. J. Gastroenterol. 2008; 103; 1625-1630.
22. Tseng PH, Lee YC, Chiu HM et al. Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J. Clin. Gastroenterol. 2008; 42; 1074-1079.
23. Wong WM, Lam SK, Hui WM et al. Long-term prospective follow-up of endoscopic esophagitis in southern Chinese-prevalence and spectrum of the disease. Aliment. Pharmacol. Ther. 2002; 16; 2037-2042.
24. American Joint Committee on Cancer. Esophagus and esophagogastric junction. In Fleming ID ed. AJCC cancer staging manual, 7th edn. New York, NY: Springer, 2009; 129-144.
25. Lauwers GY, Riddell RH. Gastric epithelial dysplasia. Gut 1999; 45; 784-790.
26. Law SY, Fok M, Cheng SW, Wong J. A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia. Surg. Gynecol. Obstet. 1992; 175; 107-112.
27. Kamangar F, Qiao YL, Blaser MJ et al. Helicobacter pylori and esophageal and gastric cancers in a prospective study in China. Br. J. Cancer 2007; 96; 172-176.
28. Kalish RJ, Clancy PE, Orringer MB, Appelman HD. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gastroenterology 1984; 86; 461-467.
29. Smith RR, Hamilton SR, Boitnott JK, Rogers EL. The spectrum of carcinoma arising in Barrett's esophagus. A clinicopathologic study of 26 patients. Am. J. Surg. Pathol. 1984; 8; 563-573.
30. Leers JM, DeMeester SR, Chan N et al. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus. J. Thorac. Cardiovasc. Surg. 2009; 138; 594-602.
31. Dolan K, Morris AI, Gosney JR, Field JK, Sutton R. Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease? J. Gastroenterol. Hepatol. 2004; 19; 24-30.
32. Ectors N, Driessen A, De Hertog G et al. Is adenocarcinoma of the esophagogastric junction or cardia different from Barrett adenocarcinoma? Arch. Pathol. Lab. Med. 2005; 129; 183-185.
33. Yuasa N, Miyake H, Yamada T, Ebata T, Nimura Y, Hattori T. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction. World J. Surg. 2006; 30; 364-371.
34. Hasegawa S, Yoshikawa T, Cho H et al. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J. Surg. 2009; 33; 95-103.
35. Hirota WK, Loughney TM, Lazas DJ et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116; 277-285.
36. Egi Y, Ito M, Tanaka S et al. Role of Helicobacter pylori infection and chronic inflammation in gastric cancer in the cardia. Jpn. J. Clin. Oncol. 2007; 37; 365-369.
37. Watari J, Moriichi K, Tanabe H et al. Differences in genetic instability and cellular phenotype among Barrett's, cardiac, and gastric intestinal metaplasia in a Japanese population with Helicobacter pylori. Histopathology 2009; 55; 261-269.
38. Kanamoto A, Nakanishi Y, Ochiai A et al. A case of small polypoid esophageal carcinoma with multidirectional differentiation, including neuroendocrine, squamous, ciliated glandular, and sarcomatous components. Arch. Pathol. Lab. Med. 2000; 124; 1685-1687.
39. Yachida S, Nakanishi Y, Shimoda T et al. Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases. Oncology 2004; 66; 218-225.
40. Chak A, Lee T, Kinnard MF et al. Familial aggregation of Barrett's esophagus, esophageal adenocarcinoma, and esophagogastric junctional adenocarcinoma in Caucasian adults. Gut 2002; 51; 323-328.
41. Guo W, Blot WJ, Li JY et al. A nested case-control study of esophageal and stomach cancers in the Linxian nutrition intervention trial. Int. J. Epidemiol. 1994; 23; 444-450.
42. Li JY, Ershow AG, Chen ZJ et al. A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int. J. Cancer 1989; 43; 755-761.
43. Cheung WY, Zhai R, Kulke MH et al. Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk. Carcinogenesis 2009; 30; 1363-1367.
44. Savage SA, Abnet CC, Mark SD et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2004; 13; 2251-2257.
45. Wang J, Pan HF, Hu YT, Zhu Y, He Q. Polymorphism of IL-8 in 251 allele and gastric cancer susceptibility: a meta-analysis. Dig. Dis. Sci. 2010; 55; 1818-1823.
46. Zhang J, Su XQ, Wu XJ et al. Effect of body mass index on adenocarcinoma of gastric cardia. World J. Gastroenterol. 2003; 9; 2658-2661.